Biogen· @biogen · X·· 4 小时前AI 评分35
AI 导读
#News：渤健新创投（Biogen New Ventures）很荣幸参与 Altay Therapeutics 的 A 轮融资，以支持一款用于面肩肱型肌营养不良症（FSHD）的在研口服疗法的开发。了解更多：https://bit.ly/4s2mBgW
正文
#News: Biogen New Ventures is proud to participate in Altay Therapeutics' Series A financing to support the development of an investigational oral therapy for facioscapulohumeral muscular dystrophy (FSHD). Learn more: https://bit.ly/4s2mBgW
来源：Biogen · x.com